全文获取类型
收费全文 | 25361篇 |
免费 | 1657篇 |
国内免费 | 135篇 |
专业分类
耳鼻咽喉 | 282篇 |
儿科学 | 763篇 |
妇产科学 | 513篇 |
基础医学 | 3245篇 |
口腔科学 | 702篇 |
临床医学 | 2693篇 |
内科学 | 6046篇 |
皮肤病学 | 668篇 |
神经病学 | 2522篇 |
特种医学 | 648篇 |
外科学 | 2402篇 |
综合类 | 118篇 |
一般理论 | 8篇 |
预防医学 | 2204篇 |
眼科学 | 418篇 |
药学 | 1815篇 |
中国医学 | 81篇 |
肿瘤学 | 2025篇 |
出版年
2023年 | 211篇 |
2022年 | 409篇 |
2021年 | 856篇 |
2020年 | 497篇 |
2019年 | 764篇 |
2018年 | 915篇 |
2017年 | 595篇 |
2016年 | 741篇 |
2015年 | 840篇 |
2014年 | 1094篇 |
2013年 | 1409篇 |
2012年 | 2125篇 |
2011年 | 2127篇 |
2010年 | 1123篇 |
2009年 | 1038篇 |
2008年 | 1716篇 |
2007年 | 1672篇 |
2006年 | 1630篇 |
2005年 | 1581篇 |
2004年 | 1382篇 |
2003年 | 1239篇 |
2002年 | 1140篇 |
2001年 | 121篇 |
2000年 | 102篇 |
1999年 | 167篇 |
1998年 | 195篇 |
1997年 | 173篇 |
1996年 | 156篇 |
1995年 | 131篇 |
1994年 | 98篇 |
1993年 | 107篇 |
1992年 | 84篇 |
1991年 | 56篇 |
1990年 | 51篇 |
1989年 | 63篇 |
1988年 | 46篇 |
1987年 | 35篇 |
1986年 | 48篇 |
1985年 | 49篇 |
1984年 | 44篇 |
1983年 | 44篇 |
1982年 | 35篇 |
1981年 | 40篇 |
1980年 | 41篇 |
1979年 | 26篇 |
1978年 | 20篇 |
1977年 | 14篇 |
1976年 | 15篇 |
1975年 | 15篇 |
1974年 | 14篇 |
排序方式: 共有10000条查询结果,搜索用时 859 毫秒
1.
Troppmair Teresa Egger J. Krösbacher A. Zanvettor A. Schinnerl A. Neumayr A. Baubin M. 《Der Anaesthesist》2022,71(4):272-280
Die Anaesthesiologie - Die Qualität eines Rettungssystems zeichnet sich auch durch den effizienten Einsatz seiner personellen und Fahrzeugressourcen aus. So können im berechtigten Fall... 相似文献
2.
3.
4.
5.
Maria Gonzalez-Cao Cristina Carrera Juan Francisco Rodriguez Moreno Pedro Rodríguez-Jiménez Mónica Antoñanzas Basa Rosa Feltes Ochoa Teresa Puertolas Eva Muñoz-Couselo José Luis Manzano Ivan Marquez-Rodas Juan Martín-Liberal Ainara Soria Pilar Lopez Criado Almudena Garcia-Castaño Aram Boada Pablo Ayala de Miguel Susana Puig Guillermo Crespo Alfonso Berrocal 《Journal of the American Academy of Dermatology》2021,84(5):1412-1415
6.
7.
Fabio Frosio Federico Mocchegiani Grazia Conte Enrico Dalla Bona ANDrea Vecchi Daniele Nicolini Marco Vivarelli 《World journal of gastrointestinal surgery》2019,(6)
Cholangiocarcinoma(CCA) is a malignant tumor of the biliary system and includes, according to the anatomical classification, intra hepatic CCA(iCCA),hilar CCA(hCCA) and distal CCA(dCCA). Hilar CCA is the most challenging type in terms of diagnosis, treatment and prognosis. Surgery is the only treatment possibly providing long-term survival, but only few patients are considered resectable at the time of diagnosis. In fact, tumor's extension to segmentary or subsegmentary biliary ducts, along with large lymph node involvement or intrahepatic metastases, precludes the surgical approach. To achieve R0 margins is mandatory for the disease-free survival and overall survival. In case of unresectable locally advanced hCCA, radiochemotherapy(RCT) as neoadjuvant treatment demonstrated to be a therapeutic option before either hepatic resection or liver transplantation. Before liver surgery, RCT is believed to enhance the R0 margins rate. For patients meeting the Mayo Clinic criteria, RCT prior to orthotopic liver transplant(OLT) has proved to produce acceptable 5-years survivals. In this review, we analyze the current role of neoadjuvant RCT before resection as well as before OLT. 相似文献
8.
Samira Marín-Romero Teresa Elías-Hernández María Isabel Asensio-Cruz Rocío Ortega-Rivera Raquel Morillo-Guerrero Javier Toral Emilio Montero Verónica Sánchez Elena Arellano José María Sánchez-Díaz Macarena Real-Domínguez Remedios Otero-Candelera Luis Jara-Palomares 《Archivos de bronconeumología》2019,55(12):619-626
IntroductionScales for predicting venous thromboembolism (VTE) recurrence are useful for deciding the duration of the anticoagulant treatment. Although there are several scales, the most appropriate for our setting has not been identified. For this reason, we aimed to validate the DASH prediction score and the Vienna nomogram at 12 months.MethodsThis was a retrospective study of unselected consecutive VTE patients seen between 2006 and 2014. We compared the ability of the DASH score and the Vienna nomogram to predict recurrences of VTE. The validation was performed by stratifying patients as low-risk or high-risk, according to each scale (discrimination) and comparing the observed recurrence with the expected rate (calibration).ResultsOf 353 patients evaluated, 195 were analyzed, with an average age of 53.5 ± 19 years. There were 21 recurrences in 1 year (10.8%, 95% CI: 6.8%-16%). According to the DASH score, 42% were classified as low risk, and the rate of VTE recurrence in this group was 4.9% (95% CI: 1.3%-12%) vs. the high-risk group that was 15% (95% CI: 9%-23%) (p <.05). According to the Vienna nomogram, 30% were classified as low risk, and the rate of VTE recurrence in the low risk group vs. the high risk group was 4.2% (95% CI:0.5%-14%) vs. 16.2% (95% CI: 9.9%-24.4%) (p <.05).ConclusionsOur study validates the DASH score and the Vienna nomogram in our population. The DASH prediction score may be the most advisable, both because of its simplicity and its ability to identify more low-risk patients than the Vienna nomogram (42% vs. 30%). 相似文献
9.
10.